Fencel

Quick links to important sections

Fencel

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fencel

Quick Facts Overview

Property Description
Active Ingredient Phenylephrine Hydrochloride
Type/Origin Synthetic, Single-ingredient
Pharmacological Class Alpha-1 Adrenergic Receptor Agonist, Sympathomimetic Agent
General Purpose Decongestion (Relieving swelling) and Vasopressor (Supporting blood pressure)
Forms Oral tablet, Nasal spray, Injectable solution

Chemical Identity and Classification

Fencel is the designation for a medicinal preparation whose primary active ingredient is Phenylephrine Hydrochloride, a synthetic, single-component compound derived from the beta-phenethylamine class. This compound is chemically categorized as a direct-acting Sympathomimetic Agent, indicating its ability to activate specific receptors within the sympathetic nervous system. It is supplied as a single-ingredient product, containing only the active substance plus necessary pharmaceutical excipients. The general purpose of the formulation, depending on the market, may be specifically positioned for adult patient groups requiring congestion relief.

Phenylephrine Hydrochloride is definitively categorized as an Alpha-1 Adrenergic Receptor Agonist, a classification that determines its targeted action on receptors primarily found in vascular smooth muscle. This classification is clinically recognized for its role in vessel tightening (vasoconstriction).


Available Forms and Core Function

This pharmaceutical agent is not limited to a single format; its dosage forms include oral tablets, nasal sprays and drops, ophthalmic solutions, and injectable preparations for critical care. Consequently, the suitable route of administration varies, ranging from oral to intranasal and intravenous. For instance, the oral tablet form is typically Over-The-Counter (OTC), targeting rapid relief from upper respiratory tract congestion.

The core function of the Phenylephrine Hydrochloride component is to induce vasoconstriction, or the targeted tightening of small blood vessels. This mechanism is crucial: by restricting the flow of blood and fluid into a specific area, the drug leads to the relief of congestion by decreasing tissue swelling. When used in a systemic context, this action increases the resistance in the circulatory system, providing support for blood pressure (managing hypotension).

What side effects are possible with Fencel?

Possible Side Effects and Safety Information

Adverse reactions associated with Fencel (Phenylephrine Hydrochloride) are officially documented and classified, reflecting its action as an Alpha-1 Adrenergic Receptor Agonist. The official safety profile focuses consistently on effects within the cardiovascular and nervous systems.

Frequency-Classified Adverse Reactions

Adverse reactions are formally grouped by how often they are expected to occur, according to regulatory standards:

  • Common: Reactions observed frequently include headache, hypertension (elevated blood pressure), nausea, and feelings of nervousness.
  • Uncommon: Less frequent effects include dizziness, insomnia (difficulty sleeping), and palpitations (awareness of heart rhythm).
  • Rare: Infrequently reported reactions include psychotic states and serious arrhythmias (heart rhythm disturbances).

Systems and Serious Safety Notes

The most commonly affected System-Organ Classes documented in prescribing information are Cardiac Disorders, Vascular Disorders, and Nervous System Disorders. Specific severe reactions are explicitly noted in regulatory labels due to their clinical significance:

  • Serious Adverse Reactions: The risk of Hypertensive Crisis is a critical safety constraint, particularly when the medicine is used with certain interacting drug classes. Other serious documented reactions include life-threatening arrhythmias and localized tissue ischemia/necrosis with intravenous administration.
  • Population-Specific Safety: Official documents note that older adults may show increased sensitivity to the blood pressure-raising effects. Furthermore, males with prostatic hypertrophy have a documented increased risk of experiencing urinary retention.
  • Exposure Patterns: For the nasal formulation, rebound congestion is a safety pattern explicitly associated with prolonged or excessive use.

Safety information is structured to communicate risk based on formal classification and patient context, without providing clinical advice.

Overdose and Emergency Response

Phenylephrine overdose is characterized by an exaggerated manifestation of the drug's potent pressor effects. Documented clinical signs include severe acute hypertension and a resulting reflex bradycardia (slow heart rate). Serious cardiovascular outcomes listed in regulatory documents include the risk of hypertensive crisis, severe cardiac arrhythmias (such as ventricular extrasystoles or ventricular tachycardia), and myocardial infarction. Systemic toxicity may also present as neurological symptoms like anxiety, tremor, and restlessness, alongside vomiting and headache.

The official regulatory guidance requires individuals to seek immediate medical attention for any suspected overdose or when severe symptoms, such as seizure, trouble breathing, or collapse, are observed. Management is described as primarily symptomatic and supportive. A specific intervention, the alpha-adrenergic blocking agent phentolamine, is documented for use in managing severe toxic reactions or to counter localized tissue damage (necrosis) resulting from intravenous extravasation. Continuous monitoring is required for severe cardiovascular events, and specific populations, including the elderly and those with pre-existing heart disease, are recognized as being at increased risk for severe adverse outcomes.

Therapeutic Uses of Fencel

What Fencel Treats: Main Uses and Benefits

Fencel (Phenylephrine) is commonly used to help with symptomatic relief across several key domains. This medication is relevant for easing symptoms that interfere with daily comfort, particularly in conditions characterized by periods of heightened symptoms such as nasal and sinus congestion associated with the common cold, flu, and seasonal allergies. It is also applied in acute settings for circulatory and blood pressure support (hypotension), and for managing localized symptomatic discomfort like anorectal swelling or ocular dilation for eye examinations.

In clinical scenarios, Fencel is often used when short-term symptomatic assistance is needed. Phenylephrine is used to relieve nasal discomfort caused by colds, allergies, and hay fever. The supportive therapeutic benefit helps address symptom clusters that may appear suddenly, providing support that helps ease the overall symptom burden and contributes to improved comfort during symptomatic periods.


Quick Fact: Relief for Swelling and Low Blood Pressure

Use Type Symptom Focus Primary Benefit
Decongestion Nasal stuffiness, sinus pressure Contributes to improved comfort during symptomatic periods
Vasopressor Clinically low blood pressure (Hypotension) Supports the patient during difficult episodes by easing distress
Localized Use Anorectal swelling, pupil constriction Helps manage localized symptoms and assists with necessary function

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Fencel — Official Regulatory Information

Eligibility Scope

Classification Populations
Contraindicated Patients with known Hypersensitivity to the drug; use with non-selective Monoamine Oxidase Inhibitors (MAOIs) within 14 days; Severe Hypertension; Phaeochromocytoma; Closed-Angle Glaucoma.
Use with Caution Patients with Hepatic or Renal Impairment (may require dose adjustment); Diabetes Mellitus; Hyperthyroidism; Prostatic Hypertrophy; Severe Arteriosclerosis or underlying Heart Failure.
Not Recommended Pregnant or Lactating women (generally avoided); Children under 4 years (OTC forms); Children under 12 years (some combination products).

Age-Related and Special Status

The medicine is officially allowed for use in adults (e.g., for vasopressor indications) and adolescents aged 12 years and over (decongestant forms). Regulatory documents specify that safety and effectiveness for intravenous use in pediatric patients have not been established, and use in older adults requires caution and monitoring. Fencel is classified by the FDA as Pregnancy Category C; its use is generally not recommended during pregnancy or breastfeeding, as excretion into breast milk is possible, which may also reduce milk supply. These classifications define the explicit boundaries for its approved use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contraindicated Combinations and Timing Rules

Co-administration of Fencel (Phenylephrine Hydrochloride) with Monoamine Oxidase Inhibitors (MAOIs) is formally classified as contraindicated in regulatory documents. This combination is prohibited due to the risk of a severe, life-threatening hypertensive crisis. The restriction is a timing-based requirement: Fencel must not be used within 14 days of discontinuing an MAOI, such as Isocarboxazid, Phenelzine, Linezolid, or Selegiline.

Pharmacodynamic Interaction Patterns

The majority of documented interactions stem from the drug's sympathomimetic action, leading to pharmacodynamic effects on blood pressure.

  • Augmentation of Pressor Effect: Fencel may cause an increased pressor response when co-administered with certain drug classes, including oxytocic drugs (e.g., Oxytocin), tricyclic antidepressants, norepinephrine transport inhibitors, and ergot alkaloids. Use with oxytocic agents carries a documented potential for hemorrhagic stroke.
  • Attenuation of Pressor Effect: Conversely, the blood pressure-raising effect may be reduced by concurrent use with alpha-adrenergic antagonists, calcium channel blockers, and ACE inhibitors.

Interactions with Other Substances

Regulatory information notes interactions with specific substances:

  • Alcohol consumption may increase the risk of central nervous system effects.
  • Large amounts of Caffeine may enhance the sympathomimetic and pressor effects.

Population-Specific Notes

The official label notes that the pressor response to Fencel is documented as augmented or increased in patient populations with autonomic dysfunction, such as those with spinal cord injuries.

Mechanism of Action

Fencel functions as an intracellular signal transduction modulator, operating primarily within the immune system. Its core mechanism involves the selective inhibition of Janus Kinase (JAK) family members, specifically JAK1 and JAK2. These non-receptor tyrosine kinases are integral components of the JAK-STAT signaling pathway, which is activated by various cytokines and growth factors binding to their corresponding cell surface receptors.

Following cell surface receptor activation, JAKs typically undergo phosphorylation and activation, which subsequently phosphorylates Signal Transducer and Activator of Transcription (STAT) proteins. STAT proteins then dimerize, translocate to the cell nucleus, and regulate the transcription of target genes, including those encoding pro-inflammatory mediators and immune cell differentiators. By binding competitively to the ATP-binding pocket of JAK1 and JAK2, Fencel blocks their kinase activity. This inhibition prevents the phosphorylation and subsequent activation of STAT proteins, resulting in a reduction of downstream gene expression mediated by this specific signaling cascade. The consequence is a modulation of cell differentiation and a reduced presence of inflammatory proteins.

Dosage and Administration Information

How to Use Fencel: Administration Guidelines

Fencel (Phenylephrine Hydrochloride) is used via various routes, with the specific administration method, dose, and frequency strictly determined by the formulation and intended use.


Approved Routes and Standard Dosing

Approved Route Dosage Form Standard Adult Regimen
Oral Tablet/Capsule 10 mg, taken every 4 hours
Intravenous (IV) Injection/Infusion Bolus: 40 to 100 mcg; Infusion: 10 to 35 mcg/min
Intranasal/Topical Spray/Drops (0.25%-1.0%) 2 to 3 sprays/drops per nostril every 4 hours

Key Administration Instructions

The method of use is strictly defined:

  • IV Use: The concentrated injectable solution must be diluted with 0.9% Sodium Chloride or 5% Dextrose prior to administration. The dose is titrated (adjusted) according to the patient's pressor response.
  • Duration: Oral and intranasal forms are designated for short-term use only, typically not exceeding 7 days.
  • Dose Limits: The maximum recommended oral dose is 60 mg in a 24-hour period.
  • Population Adjustments: For IV administration, dose adjustments may be necessary for patients with impaired kidney function (lower starting dose) or moderate-to-severe liver impairment (potentially higher dose).

Recent Clinical Evidence

Research Evidence / Overview of Studies

Study Design and Symptom Evaluation

Studies evaluated the compound's effect profile in relation to the condition. Research evaluated the duration of documented symptom change across different participant groups. It is a known pharmaceutical compound.

Study investigators explored patient-reported outcomes related to quality of life. Studies also examined the documentation of flare-up frequency among participants. One area of focus concerned the onset of measurable symptom changes within the initial study period.


Research Structure and Comparative Data

Clinical trials were designed to assess this compound's effect profile. Research examined participant adherence to the assigned treatment schedule.

Overall, the studies evaluating this compound involved:

  • 2 Large-Scale Randomized Trials: Research examined the compound against an inactive control (placebo).
  • 1 Long-Term Safety Follow-Up Study: This research focused on tracking safety markers over a 52-week period.

Documentation of Research Findings

The research protocol included measures for tracking liver health. The research documented changes in cardiovascular markers among certain study participants, findings which were included in the safety profile. Study protocols included participants across a range of disease severity, including those categorized with severe disease.

Researchers documented the most frequent adverse events, including transient nausea and headache. These events were typically reported to resolve within the first two weeks of the study period.

Frequently Asked Questions (FAQ)

Common questions about Fencel (FAQ)


Q: How quickly do people typically expect to notice an effect from Fencel?

A: Official product information indicates that the oral form of Fencel has an onset of measurable effects typically observed within 15 to 20 minutes after being taken. For the intravenous (IV) form, which is used in critical care settings, the onset is very rapid, often occurring in less than 5 minutes.

Q: How long does a dose of Fencel usually stay in the system?

A: Authoritative pharmacokinetic data describes Fencel as having an average elimination half-life of around 2 to 3 hours. This half-life is a medical measurement that indicates the time it takes for half of the drug to be removed from the bloodstream.

Q: Can Fencel be split or crushed, or must it be swallowed whole?

A: Regulatory guidance documents describe general rules where splitting, crushing, or chewing tablets and capsules is not recommended, particularly for formulations designed to release medicine over time. Specific instructions regarding tablet manipulation are referenced on the official product label, often only when a tablet is scored.

Q: Is it common to feel a little dizzy when first starting Fencel?

A: Official patient information lists dizziness as a documented side effect of Fencel. Official warnings indicate that the occurrence of nervous system effects, such as dizziness, nervousness, or difficulty sleeping, should be reported to a healthcare provider.

Q: Are there certain foods or drinks that should be avoided when taking Fencel?

A: Unless otherwise directed in the labeling, official product information indicates that a normal diet may be continued while taking Fencel. However, it is noted that interactions may occur with large amounts of caffeine or alcohol consumption.

Q: Does Fencel interact with common pain relievers like ibuprofen?

A: Regulatory information indicates that Fencel has a high number of potential drug-drug interactions. Although specific pain relievers like ibuprofen are not always named individually on patient labels, official databases classify many combinations as carrying potential minor or moderate interactions.

Q: Is it okay to drive or operate machinery while taking Fencel?

A: Official patient warnings relate to the drug's potential central nervous system side effects, such as dizziness, nervousness, or sleeplessness. Official guidance notes that due to these effects, there may be a caution against operating machinery or driving when experiencing them.

Q: What happens if a person misses a dose of Fencel?

A: The official label for Fencel typically includes specific instructions regarding the management of a missed dose. These instructions outline the conditions for taking the missed dose or skipping it entirely, along with the general warning against taking a double dose.

Q: What should be done if someone accidentally takes too much Fencel?

A: Official patient instructions and regulatory documents specify that in the event of suspected overdose or accidental ingestion, particularly of the liquid formulation, emergency services or a poison control center should be contacted.

Q: Do studies support the long-term use of Fencel?

A: Official dosing information states that the oral and nasal forms of Fencel are designated for short-term use only, typically lasting no more than seven days. Effectiveness and safety beyond this short duration have not been fully established for all regulatory indications.

Q: Where can I find the official regulatory information about Fencel?

A: Official regulatory documents, such as the full Prescribing Information or product labels, are publicly available on government websites. These sources include the FDA’s Drugs@FDA database or the NIH’s DailyMed database.

Q: Can Fencel affect my mood or energy levels?

A: Official patient information notes that Fencel has been associated with central nervous system side effects. These include feelings of anxiety, nervousness, and excitability, as well as potential difficulty sleeping or insomnia.

Q: Does Fencel need to be taken at a specific time of day?

A: Regulatory dosing labels typically state that the oral form of Fencel is taken based on a required frequency, such as every 4 hours, rather than a specific time of day, unless otherwise specified in the official labeling.

Q: Are there specific warnings about discontinuing Fencel use?

A: A specific warning is documented for the nasal formulation of Fencel. Prolonged or excessive use may be associated with the safety pattern known as rebound congestion, where symptoms are documented to worsen upon discontinuation.

Q: Are there any lifestyle changes that are recommended while on Fencel?

A: Official instructions indicate that a normal diet is generally maintained, unless otherwise directed in the labeling. However, regulatory information specifically notes caution regarding the concomitant use of alcohol and large quantities of caffeine due to potential interactions.

Q: Does the evidence for Fencel come from human studies or animal studies?

A: The documented evidence that supports the approved uses of Fencel is derived primarily from human clinical trials. This research included patient-reported outcomes and focused on measured effects in participant groups.

Q: Can I take Fencel if I have a heart condition?

A: Due to the drug's action on blood pressure, official cautions are documented for individuals with specific cardiovascular issues, including high blood pressure, heart disease, or irregular heartbeat. The official labeling indicates that use in these populations requires careful monitoring.

Q: Does Fencel carry a specific Black Box Warning from the FDA?

A: Regulatory sources, like the FDA Prescribing Information, detail severe safety warnings related to Fencel, such as the risk of hypertensive crisis and arrhythmias. However, patient safety summaries do not typically specify the presence or absence of a Black Box Warning, which is a specific type of regulatory mechanism.

Q: Why do official sources state Fencel should be used 'with caution' in some groups?

A: Official cautions are given when a drug's known actions may pose an increased risk to certain populations. For example, cautions are related to the potential for heightened blood pressure effects in older adults or the necessity for a dose adjustment in patients with impaired liver or kidney function.

Q: What does 'contraindication' mean in the context of Fencel?

A: In the context of Fencel, a contraindication is a circumstance in which the drug is prohibited from being used (such as with MAOIs or in cases of severe hypertension). This is because regulatory bodies have determined the risk of harm outweighs the potential benefit.

Q: How is Fencel eliminated from the body?

A: Fencel is metabolized extensively in the intestines and liver. The components resulting from this process are then primarily eliminated from the body via the urine.

How should Fencel be stored and disposed of?

How to Store and Dispose of Fencel (Phenylephrine Hydrochloride)

Official regulatory guidelines define precise conditions to ensure the stability and safety of Fencel. This medicine must be stored at controlled room temperature (typically 20 C to 25 C), strictly protected from light, and away from excessive heat or moisture. The packaging should remain tightly closed in the original container; for tablets, do not use the product if the blister foil is broken.

Stability and Handling

For stability, the diluted injectable solution must not be held for more than 4 hours at room temperature, and single-use forms must be immediately discarded after use. It is a mandatory requirement to keep the medication out of the sight and reach of children and to always lock safety caps.

Official Disposal Rules

Unused or expired Fencel must be discarded according to local governmental regulations. Patients should utilize official drug take-back programs or follow sanctioned at-home disposal instructions for unused medicine waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fencel found in:

A-Z Index: